Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2023-02-14 Capital/Financing Update
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the Quarter ended December 31, 2022' and is issued by ICICI Bank Limited as the monitoring agency. It reports on the utilization of proceeds from the IPO fresh issue by Supriya Lifescience Limited. The report includes detailed financial data on the deployment of funds, progress on the objects for which funds were raised, and compliance with SEBI regulations. It is a regulatory requirement under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The document is not an announcement of a report but the actual monitoring report itself, containing substantive financial data and analysis related to capital utilization and compliance. This fits the category of Capital/Financing Update (CAP), as it provides updates on the utilization of capital raised through the IPO and related financing activities.
2023-02-14 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on February 14, 2023. It specifically mentions the approval of the Unaudited Financial Results for the quarter and nine months ended December 31, 2022. The document includes detailed financial data for the quarter and nine months, along with a Limited Review report by the Statutory Auditor. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarter and nine months) indicates this is an Interim / Quarterly Report. The document is about unaudited quarterly financial results, not a full annual report or just an announcement of a report. Therefore, the correct classification is Interim / Quarterly Report (IR). The document length (15,000 characters) and detailed financial tables support this classification with high confidence. 9M 2023
2023-02-14 English
Financial Result Updates
Regulatory Filings
2023-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming earnings call scheduled for February 15, 2023, to discuss the operational and financial performance for the quarter and nine months ended December 31, 2022. It includes details such as the date, time, participants, and dial-in information. The document does not contain actual financial results or detailed analysis but serves as an announcement for the earnings call event. According to the classification rules, such notifications are classified as Call Transcript (CT) only if they contain the full transcript of the call. Since this is only an invitation/intimation for the earnings call, it does not qualify as a transcript. It is also not an Earnings Release (ER) because it does not contain financial highlights or results. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event.
2023-02-09 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter dated February 6, 2023, addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for February 14, 2023. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2022. It also mentions the closure of the trading window in compliance with insider trading regulations. The document does not contain any financial data or results itself but is an announcement of a future event related to financial reporting. The document length is short (2254 characters) and it serves as an intimation or notice rather than the actual financial report or results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-02-06 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the appointment of a new director, Mr. Manoj Deo Dorlikar, as an Additional Director and Whole Time Director. It references compliance with SEBI Listing Regulations and provides detailed information about the appointment, including the term and profile of the appointee. There is no financial data, earnings information, or report attached. The content clearly pertains to a change in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed appointment information, confirming the classification.
2023-01-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.